Search

everythinglearnresearchcommunity

for

Search:↓

JAK/STAT1 pathway causes hair loss during chemotherapy by reducing Shh in hair follicles.

Cells that move well may improve hair loss treatments by entering hair follicles.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

JAGGED1 could help regenerate tissues for bone loss and heart damage if delivered correctly.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

Cutaneous lupus patients have higher levels of certain immune cells in their blood and skin.

Id proteins, especially Id2 and Id3, are crucial for hair follicle development and stem cell regulation.

LncRNA RP11-818024.3 helps hair growth and recovery in hair loss by boosting cell survival and reducing cell death.

Canine hair follicle cells show stem cell properties, aiding hair growth.

A specific genetic trait in tumor cells is linked to longer survival without disease in certain lymphoma patients.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

The study found that a key immune pathway protecting hair follicles is reduced in a mouse model of scarring hair loss.

CDKN2AIP gene is less active in nevus sebaceous, affecting related RNA networks.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

TEDAR is crucial for skin cell differentiation and barrier formation.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

CCCA involves immune response and metabolism issues, suggesting new treatment options.

The Hedgehog signaling pathway is linked to cancer development, and targeting it with inhibitors shows promise but faces challenges like resistance.

Genetic variants in specific genes cause central centrifugal cicatricial alopecia.

A rare genetic disorder causes sparse hair and vision loss due to a CDH3 gene mutation.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

A new diagnostic model can help better diagnose and understand Alopecia Areata.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.

The CUBIC protocol allows detailed 3D visualization of proteins in mouse skin biopsies.

CRISPR/Cas9 and prime editing can potentially fix skin disorder genes safely and effectively.

Deleting the MAD2L1 gene in mice led to rapid tumor growth despite chromosomal instability.